Showing results 1 to 20 of 28
next >
| Rights | Preview | Issue Date | Title | Author(s) | Type |
| openAccess |  | 18-Dec-2019 | A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors | Pérez-Peña, Javier; Tibor Fekete, Janos; Páez, Raquel; Baliu-Piqué, Mariona; García-Saenz, José Ángel; García-Barberán, Vanesa; Manzano, Aranzazu CSIC ORCID ; Pérez-Segura, Pedro; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN ; Győrffy, Balázs; Ocaña, Alberto | artículo |
| closedAccess |  | 2005 | Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin | Yuste, Laura CSIC; Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2012 | Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer | Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID CVN ; Re-Louhau, M. F. CSIC; Seoane, Samuel CSIC ORCID; Abad, María del Mar; Calero, R.; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 30-Aug-2019 | Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer | Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Burgos, Miguel; Gómez-Juárez, Mónica; Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Alberto | artículo |
| closedAccess |  | 1999 | Cleavage of the TrkA neurotrophin receptor by multiple metalloproteases generates signalling-competent truncated forms | Díaz-Rodríguez, Elena CSIC ORCID CVN; Cabrera, Noemí CSIC; Esparís-Ogando, Azucena CSIC ORCID CVN ; Montero, Juan Carlos CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2021 | Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer | Sánchez-Fdez, Adrián; Re-Louhau, M. F. CSIC; Rodríguez-Núñez, Pablo; Ludeña, María Dolores; Matilla-Almazán, Sofía; Pandiella, Atanasio CSIC ORCID CVN ; Esparís-Ogando, Azucena CSIC ORCID CVN | artículo |
| closedAccess |  | 2000 | Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-α-converting enzyme | Montero, Juan Carlos CSIC ORCID; Yuste, Laura CSIC; Díaz-Rodríguez, Elena CSIC ORCID CVN; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 1-Jul-2009 | ERK2, but Not ERK1, Mediates Acquired and “De novo” Resistance to Imatinib Mesylate: Implication for CML Therapy | Aceves-Luquero, Clara I.; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2007 | Erk5 nuclear location is independent on dual phosphorylation, and favours resistance to TRAIL-induced apoptosis | Borges, Joana; Pandiella, Atanasio CSIC ORCID CVN ; Esparís-Ogando, Azucena CSIC ORCID CVN | artículo |
| closedAccess |  | Jan-2002 | Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2 | Esparís-Ogando, Azucena CSIC ORCID CVN ; Díaz-Rodríguez, Elena CSIC ORCID CVN; Montero, Juan Carlos CSIC ORCID; Yuste, Laura CSIC; Crespo, Piero CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2013 | ERK5/BMK1 is a novel target of the tumor suppressor VHL: Implication in clear cell renal carcinoma | Esparís-Ogando, Azucena CSIC ORCID CVN ; Prado, Alfonso; Pandiella, Atanasio CSIC ORCID CVN ; Peso, Luis del; Sánchez-Prieto, Ricardo | artículo |
| openAccess |  | 15-May-2009 | Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic target | Montero, Juan Carlos CSIC ORCID; Ocaña, Alberto; Abad, María del Mar; Ortiz-Ruiz, María Jesús CSIC; Pandiella, Atanasio CSIC ORCID CVN ; Esparís-Ogando, Azucena CSIC ORCID CVN | artículo |
| openAccess |  | 2-Feb-2022 | Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21 | Tubita, Alessandro; Lombardi, Zoe; Tusa, Ignazia; Lazzeretti, Azzurra; Sgrignani, Giovanna; Papini, Dimitri; Menconi, Alessio; Gagliardi, Sinforosa; Lulli, Matteo; Dello Sbarba, Persio; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN ; Stecca, Barbara | artículo |
| openAccess |  | 2020 | Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancer | Nieto-Jiménez, Cristina; Galán-Moya, Eva María; Corrales-Sánchez, Verónica; Noblejas-López, María del Mar; Burgos, Miguel; Domingo, Beatriz; Montero, Juan Carlos CSIC ORCID; Gómez-Juárez, Mónica; Picazo-Martinez, Maria Granada; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| closedAccess | | 1-Jun-2005 | Multifunctional role of Erk5 in multiple myeloma | Carvajal-Vergara, Xonia; Tabera, Soraya CSIC; Montero, Juan C.; Esparís-Ogando, Azucena CSIC ORCID CVN ; López-Pérez, Ricardo CSIC ORCID CVN; Mateo, Gema; Gutiérrez, Norma C.; Parmo-Cabañas, Marisa CSIC; Teixidó, Joaquín CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2016 | Neuregulin expression in solid tumors: Prognostic value and predictive role to anti-HER3 therapies | Ocaña, Alberto; Díez-González, Laura; Esparís-Ogando, Azucena CSIC ORCID CVN ; Montero, Juan Carlos CSIC ORCID; Amir, Eitan; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2008 | Neuregulins and Cancer | Montero, Juan Carlos CSIC ORCID; Rodríguez-Barrueco, Ruth; Ocaña, Alberto; Díaz-Rodríguez, Elena CSIC ORCID CVN; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2017 | ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA | Talamillo, Ana; Grande, Lara; Ruiz Ontañón, Patricia; Velásquez, Carlos; Mollinedo, Pilar; Aznar, Ángela; Esparís-Ogando, Azucena CSIC ORCID CVN ; López-López, Carlos; Lafita, M. Carmen CSIC ORCID; Berciano, María T.; Montero, Juan A.; Vázquez-Barquero, Alfonso; Segura, Víctor; Villagra, Nuria T.; Pandiella, Atanasio CSIC ORCID CVN ; Lafarga, Miguel; León, Javier CSIC ORCID CVN; Martínez-Climent, José Ángel; Sanz-Moreno, Victoria; Fernández-Luna, J. L. | artículo |
| closedAccess |  | 2005 | Overexpression of RasN17 fails to neutralize endogenous ras in MCF7 breast cancer cells | Yuste, Laura CSIC; Esparís-Ogando, Azucena CSIC ORCID CVN ; Santos de Dios, Eugenio CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2013 | Potent antimyeloma activity of a novel ERK5/CDK inhibitor | Álvarez-Fernández, Stela CSIC; Ortiz-Ruiz, María Jesús CSIC; Parrott, Tracy; Zaknoen, Sara; Ocio, Enrique M. CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID; Burrows, Francis J.; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
